Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Pancreatic Neoplasms 21Triple Negative Breast Neoplasms 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Neoplasm Metastasis 6Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Sarcoma 2Recurrence 2Rectal Neoplasms 2Gallbladder Neoplasms 2Colonic Neoplasms 2Carcinoma, Pancreatic Ductal 2Biliary Tract Neoplasms 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Resectable Pancreatic Cancer 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Neoplasms, Basal Cell 1Metastatic Pancreatic Ductal Adenocarcinoma 1Metastatic Adenocarcinoma of the Pancreas 1

Interventions

folfirinox 1Taxes 1Oxaliplatin 1Leucovorin 1Irinotecan 1HhAntag691 1Gemcitabine 1Fluorouracil 1Erlotinib Hydrochloride 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Basal Cell × Albumin-Bound Paclitaxel × 90 days × Clear all
NCT06483555 2026-04-23

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
104 enrolled
DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡